Equity Overview
Price & Market Data
Price: $0.115
Daily Change: +$0.0251 / 21.83%
Range: $0.0824 - $0.118
Market Cap: $18,425,440
Volume: 1,090,655
Performance Metrics
1 Week: -7.79%
1 Month: -2.86%
3 Months: -10.18%
6 Months: 24.40%
1 Year: -51.87%
YTD: 8.43%
Details
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.